This Month in AJP

There are no reported biomarkers to predict progression of small renal masses (SRMs). Using peptidomics, Di Meo et al (Am J Pathol, AJPA_2019_399) identified new non-invasive urinary peptide biomarkers for early-stage renal cell carcinoma (RCC)-SRMs. Urinary peptides distinguished clear cell RCC-SRM from healthy controls and renal oncocytoma. These non-invasive diagnostic and prognostic biomarkers may help improve clinical decision-making as well as patient management.
Source: American Journal of Pathology - Category: Pathology Authors: Tags: This Month in AJP Source Type: research